CHEMO-THERAPEUTIC SUBSTANCES CONTAINING BETA HALOGENETHYLAMINE COMPOUNDS, FOR USE AS SYMPATHOLYTIC AND ADRENOLYTIC AGENTS AND AS AN AGENT AFFECTING THE CENTRAL NERVOUS SYSTEM